Should treatment recommendations for lipid lowering drugs be based on absolute coronary risk or risk reduction?
- 11 March 2000
- Vol. 320 (7236) , 677-679
- https://doi.org/10.1136/bmj.320.7236.677
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework.1998
- West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials.1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?BMJ, 1994